Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

NCT01442376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Nausea and Vomiting

Interventions

DRUG: Palonosetron
DRUG: Palonosetron
DRUG: Ondansetron
DRUG: Placebo to Ondansetron
DRUG: Placebo to Ondansetron
DRUG: Placebo to Palonosetron

Sponsor

Helsinn Healthcare SA